Viking Therapeutics Inc.

25.57
-0.22 (-0.85%)
At close: Apr 24, 2025, 3:59 PM
25.61
0.16%
Pre-market: Apr 25, 2025, 07:42 AM EDT

Viking Therapeutics Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 FY 2018 FY 2017 FY 2016
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019 Dec 31, 2018 Dec 31, 2017 Dec 31, 2016
n/a n/a n/a n/a n/a n/a n/a n/a n/a
n/a 292K 291K 296K 277K 260K n/a n/a n/a
n/a -292K -291K -296K -277K -260K n/a n/a n/a
-150.92M -100.83M -70.36M -55.68M -42.66M -32.69M -26.16M -19.07M -13.85M
n/a 15.02M 1.59M 703K 3.23M 7.05M 3.24M 1.27K n/a
-109.96M -85.89M -68.87M -54.99M -39.49M -25.78M -22.06M -20.58M -14.73M
-109.96M -85.89M -67.38M -54M -36.05M -25.78M -22.06M -20.58M -14.73M
49.28M 37.02M 16.12M 10.7M 10.73M 9.13M 7.12M 5.33M 4.85M
101.64M 63.81M 54.23M 44.98M 31.93M 23.56M 19.04M 13.74M 9M
n/a n/a n/a n/a n/a n/a 1.4M 344.93K 1.06M
150.92M 100.83M 70.36M 55.68M 42.66M 32.69M 26.16M 19.07M 13.85M
n/a 88K n/a 18K 106K 146K 404K 1.28M 1.81M
n/a n/a n/a n/a n/a n/a n/a n/a n/a
n/a 100.83M 70.36M 55.68M 42.66M 32.69M 26.16M 19.07M 13.85M
n/a n/a -1.49M -988K -3.44M 6.99M -2.71M 1.85M 1.95M
109.04M 94.35M 76.83M 77.2M 72.6M 71.96M 57.58M 25.98M 16.28M
109.04M 94.35M 76.83M 77.2M 72.6M 71.96M 57.58M 25.98M 16.28M
-1.01 -0.91 -0.88 -0.7 -0.5 -0.36 -0.38 -0.79 -0.9
-1.01 -0.91 -0.88 -0.7 -0.5 -0.36 -0.38 -0.79 -0.9
-150.92M -100.83M -70.36M -55.39M -42.66M -25.37M 4.66M 442.88K 1.15M
n/a -100.83M -70.36M -55.68M -42.66M -25.63M -21.5M -18.63M -12.7M
n/a 292K 291K 296K 277K 260K 26.16M 19.07M 13.85M